Oncotarget is a freely accessible multidisciplinary journal. It publishes online papers in weekly issues, which can be reproduced on special demand. It was founded in 2010. Its chief editors are Andrei Gudkov and Mikhail Blagoskolonny from Roswell Institute of Cancer. Their mission is to widely and rapidly avail scientific results, share exceptional discoveries with the public, remove boundaries between specialties, connect various areas of biomedical science, and foster applications of clinical and basic science in fighting disease. The journal has contributed to scientific progress under the leadership of famous researchers. This success has made them to start sections outside oncology.
Oncotarget operates as an international peer-reviewed journal that looks into the pathological roots of all cancers, potential therapy targets and treatment procedures employed to improve the care given to cancer patients. It also focuses on the effect of management programs and new therapeutic agents and protocols on patient perspectives like satisfaction, adherence, and quality of life. In addition, Oncotarget provides sufficient evidence of existing and new treatments and seek to describe their usage in terms of acceptance and eventual uptake by the patient and the healthcare expert. Oncotarget publishes papers in the areas of pathology, age-related diseases, endocrinology, immunology and physiology. These fields explain about the complexity of growth of tumor and the reliability of human organisms.
Nevertheless, conflict of interest arises when a reviewer, editor or author has personal or financial relationships that improperly affect his or her actions. The possibility of a conflict of interest exists whether or not a person believes that the relationship influences his or her scientific decision. Financial relationships such as consultancies, stock ownership, employment, paid expert testimony, and honoraria as well as academic competition and personal relationships must be declared. The authors have the responsibility of providing a detailed statement of conflict of interest on the title page of their submitted work. Notably, manuscripts cannot move to the peer review stage unless they include this statement to ensure that the reviewers and editors are aware of any pending issues. Generally, all submissions to Oncotarget undergo a timely and unbiased peer review process. Reviewers, editors and authors are supposed to adhere to the publishing codes of conducts. Check the journal at SCImago Journal & Country Rank.